Evidence map›Paper›PMID 36568365›Full record

ArticleFrontiers in genetics2022

Identification of optimal reference genes for gene expression normalization in human osteosarcoma cell lines under proliferative conditions.

Xiaoming Dong, Qiwei Yang, Zhenwu Du, Guizhen Zhang, Chuankai Shi, Xuyuan Qin, Yang Song

Abstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Onion (International journal of molecular sciences · 2024
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Xiaoming DongMedical Center of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Qiwei YangMedical Center of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Zhenwu DuMedical Center of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Guizhen ZhangMedical Center of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Chuankai ShiMedical Center of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.
Xuyuan QinGene Testing Center of Changchun Tumor Hospital, Changchun, China.
Yang SongMedical Center of Orthopaedics, The Second Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular pathogenesis and therapeutic target research studies on osteosarcoma (OS) have developed well during the last few years using various OS cell lines with reverse transcription quantitative polymerase chain reaction (RT-qPCR). However, the identification of suitable reference genes of RT-qPCR for OS cell lines has not been reported. Here, we conducted the normalization research of 12 reference genes (GAPDH, ACTB, 18S, B2M, ALAS1, GUSB, HPRT1, HMBS, PPIA, PUM1, RPL29, and TBP) for gene expression analysis in four kinds of human OS cell lines (U2OS, Saos-2, HOS, and MG-63) to improve the investigation of molecular mechanisms and the accuracy of diagnosis and prognostic molecular targets of OS. The gene expression stability and applicability of the 12 reference gene candidates were determined using geNorm, NormFinder, and BestKeeper software. The results indicated that PUM1 and the combination of PPIA + ALAS1 were recommended as the optimal reference gene in these four different sources of human OS cell lines under proliferative conditions. The present study identified the most suitable reference genes and reference gene combinations for OS cell lines under proliferative conditions in order to use in gene expression profile analysis. A reliable standardized method has the potential to improve the understanding of the biological mechanisms underlying OS in the future.

Indexed as

gene expressionhuman osteosarcomanormalizationreference genereverse transcription quantitative polymerase chain reaction

Identifiers

PMID36568365
PMCPMC9780483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.